Memphasys Ltd (AU:MEM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Memphasys Ltd reports promising results from a study on its Felix™ System’s effectiveness in improving equine sperm quality for artificial insemination, with commercialization expected within the next 12 months. The system offers quicker sperm processing and is poised to capture a significant share of the estimated $681 million global equine AI market. A comprehensive three-year study is underway, aiming to establish the Felix™ System as a leading technology in equine breeding.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.